SPC-A1 cells are wild-type for both KRAS and EGFR [25, 26], unlike A549 cells which are mutant for KRAS and PC3 cells mutant for EGFR. Therefore, it is possible that transdifferentiation of lung cancer cells might be affected by different oncogenic mutation status. Here, KRAS is linked to lung cancer.